article thumbnail

2024 Technology and Life Sciences IPO Report

JD Supra: Mergers

Wilson Sonsini's 2024 Technology and Life Sciences IPO Report provides in-depth analysis on 33 initial public offerings (IPOs) completed by U.S.-based based technology and life sciences companies in 2024 with deal values exceeding $75 million. By: Wilson Sonsini Goodrich & Rosati

IPO 161
article thumbnail

Reverse Mergers as an IPO Alternative

Deal Lawyers

Despite a bit of a checkered reputation, non-SPAC reverse mergers are still a thing, and this excerpt from a recent WilmerHale memo (p. 14) says that there’s been an uptick in these deals and that, for some companies, they are an attractive alternative to an IPO: The trend of declining public company valuations (including a […]

IPO 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Are You Ready for a Hong Kong IPO?

JD Supra: Mergers

With deep and liquid capital markets offering unique access to the Mainland China investor market, many international businesses are considering pursuing their IPOs in Hong Kong. By: Skadden, Arps, Slate, Meagher & Flom LLP

IPO 177
article thumbnail

The 2025 IPO Market

JD Supra: Mergers

Are we headed for an IPO rebound in 2025? According to a recent CNBC article, a major window for the IPO market could be opening.

IPO 161
article thumbnail

US Capital Markets Midyear Report: The Revival of IPOs and a Possible Turning Point

JD Supra: Mergers

capital markets’ resilience and ability to adapt, IPOs, debt markets and mergers and acquisitions (and related financings) have shown substantial increases over 2023. As a testament to the U.S.

IPO 177
article thumbnail

Guide to D&O Insurance for SPAC IPOs, 2024 Edition

JD Supra: Mergers

As they go through their initial public offering (IPO) and the subsequent merger & acquisition (M&A) process, special purpose acquisition companies (SPACs) face many regulatory, legal, and business hurdles. Obtaining the appropriate amount and type of insurance for each stage of their life cycle is one of them.

IPO 161
article thumbnail

SEC Adopts Final Rules Related to SPAC IPOs and DeSPAC Transactions

JD Supra: Mergers

1] The Final Rules are intended to provide enhanced protections for investors in the initial public offerings (IPOs) of SPACs and the subsequent business combination transactions of SPACs with private operating companies (“de-SPAC transactions”). By expanding the disclosure requirements for SPAC IPOs (on. By: Robinson & Cole LLP

IPO 177